January 28, 2014
A Delaware federal judge on Tuesday granted Endo Pharmaceuticals Inc. a victory in its patent infringement suit against Mylan Pharmaceuticals Inc., ruling Endo's patent for migraine medication Frova was valid and would be infringed by Mylan's planned generic version.